CanniMed Therapeutics Inc. (TSE:CMED – Get Free Report)’s stock price traded down 5.3% on Monday . The stock traded as low as C$27.00 and last traded at C$27.00. 52,208 shares were traded during mid-day trading, a decline of 87% from the average session volume of 387,394 shares. The stock had previously closed at C$28.50.
CanniMed Therapeutics Price Performance
The business’s 50 day moving average price is C$27.00.
About CanniMed Therapeutics
CanniMed Therapeutics Inc operates as a plant biopharmaceutical company that specializes in medical cannabis. The company cultivates and sells pharmaceutical-grade cannabis products in dried herbal and oil forms for Canadian patients. It also offers herbal cannabis and cannabis oil; and vaporizers, consumable vaporizer accessories, and herb mills.
See Also
- Five stocks we like better than CanniMed Therapeutics
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for CanniMed Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanniMed Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
